Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 2;14(1):212.
doi: 10.3390/cancers14010212.

Lymph Node Involvement in Early-Stage Cervical Cancer: Is Lymphangiogenesis a Risk Factor? Results from the MICROCOL Study

Matteo Tantari  1   2 , Stefano Bogliolo  3 , Matteo Morotti  1 , Vincent Balaya  1   4 , Florent Bouttitie  5 , Annie Buenerd  6 , Laurent Magaud  7   8 , Fabrice Lecuru  9   10 , Benedetta Guani  1   11   12 , Patrice Mathevet  1   13 , On Behalf Of The Senticol Group
Affiliations

Lymph Node Involvement in Early-Stage Cervical Cancer: Is Lymphangiogenesis a Risk Factor? Results from the MICROCOL Study

Matteo Tantari et al. Cancers (Basel). .

Abstract

Background: In patients with cervical cancer, the presence of tumoral lymph-vascular space invasion (LVSI) is the main risk factor for pelvic lymph node metastasis (PLNM). The objective of this study was to evaluate the presence of several markers of lymphangiogenesis in early-stage cervical cancer and their correlation with PLNM and tumoral recurrence. Materials and Methods: Seventy-five patients with early-stage cervical carcinoma underwent sentinel lymph node (SLN) sampling in association with complete pelvic lymph node dissection. Primary tumors were stained with the following markers: Ki67, D2-40, CD31 and VEGF-C. A 3-year follow-up was performed to evaluate the disease-free survival. Results: Overall, 14 patients (18.6%) had PLNM. Positive LVSI was seen in 29 patients (38.6%). There was a significant correlation between LVSI evidenced by H/E staining and PLNM (p < 0.001). There was no correlation between high Ki67, CD31, D2-40, and VEGF-C staining with PLNM or tumor recurrence. Conclusions: Our data support that lymphatic spread does not require the proliferation of new lymphatic endothelial cells in early-stage cervical cancer. These results emphasize the importance of pre-existing peritumoral lymphatic vessels in the metastatic process in early cervical cancer. None of the markers of lymphangiogenesis and proliferation assessed in this study were predictive of PLNM or recurrence.

Keywords: angiogenesis; cervical cancer; lymph nodal metastasis; lymph-vascular space invasion; lymphangiogenesis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure A1
Figure A1
H/E staining and D2-40 antibody staining in emboli detection. Examples of detection of lymphatic invasion in H&E staining and D2-40 antibody staining. (A) Detection of peripheric emboli in H&E staining (A1) and D2-40 antibody staining (A2) (original magnification 200×). (B) Unclear detection of intra-tumoral emboli in H&E staining (B1), after D2-40 antibody staining the intra-tumoral emboli detection appear clear (original magnification 400×) (B2).
Figure A2
Figure A2
Cytoplasmic VEGF-C antibody staining. Exemples of cytoplasmic VEGF-C antibody staining in squamous cell carcinoma and adenocarcinoma of the cervix. The cytoplasmic staining intensity was scored from 0 (not staining) to 3 (most intensely stained). (A) Squamous cells carcinoma: (A1) staining score 1+ (original magnification 200×); (A2) staining score 2+ (original magnification 400×). (B) Adenocarcinoma: (B1) staining score 1+ in tumor area and staining score 0 in normal gland (original magnification 400×); (B2) staining score 2+ (original magnification 400×); (B3) staining score 3+ (original magnification 400×); (B4) staining score 3+ (original magnification 200×).
Figure A3
Figure A3
Cytoplasmic staining with D2-40 antibody. Examples of the pattern of podoplanin D2-40 antibody expression in squamous cell carcinoma and adenocarcinoma of the cervix. (A) Focal weakly staining in squamous carcinoma (score 1a) original magnification 400×. (B) Diffuse weakly staining in adenocarcinoma (score 1b) original magnification 400×. (C) Focal strong staining in squamous carcinoma (score 2a) original magnification 200×. (D) Diffuse strong staining in squamous carcinoma (score 2b) original magnification 200×. (E) Diffuse strong staining in adenocarcinoma (score 2b) original magnification 400×.
Figure 1
Figure 1
ROC curve: LVSI detected by H/S and positive lymph node.
Figure 2
Figure 2
DFS in patients with positive and negative LN. LN−: negative lymph node; LN+: positive lymph node.
See this image and copyright information in PMC

References

    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Sedlis A., Bundy B.N., Rotman M.Z., Lentz S.S., Muderspach L.I., Zaino R.J. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. Gynecol. Oncol. 1999;73:177–183. doi: 10.1006/gyno.1999.5387. - DOI - PubMed
    1. Ho C.M., Chien T.Y., Huang S.H., Wu C.J., Shih B.Y., Chang S.C. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy. Gynecol. Oncol. 2004;93:458–464. doi: 10.1016/j.ygyno.2004.01.026. - DOI - PubMed
    1. Delgado G., Bundy B., Zaino R., Sevin B.U., Creasman W.T., Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. Gynecol. Oncol. 1990;38:352–357. doi: 10.1016/0090-8258(90)90072-S. - DOI - PubMed
    1. Monk B.J., Wang J., Im S., Stock R.J., Peters W.A., III, Liu P.Y., Barrett R.J., II, Berek J.S., Souhami L., Grigsby P.W., et al. Rethinking the use of radiation and chemotherapy after radical hysterectomy: A clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol. Oncol. 2005;96:721–728. doi: 10.1016/j.ygyno.2004.11.007. - DOI - PubMed

LinkOut - more resources